We therefore investigated SLC1A5 mRNA and SLC1A5 protein expression in a large number of breast tumours to better understand the potential role of this important transporter of Gln in BC and its molecular subtypes, particularly in luminal ER + disease. This evidence concerns the gene SLC1A5 and breast cancer.